A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE).

J Criner, Gerard; Sue, Richard; Wright, Shawn; Dransfield, Mark; Rivas-Perez, Hiram; Wiese, Tanya; C Sciurba, Frank; L Shah, Pallav; M Wahidi, Momen; Goulart de Oliveira, Hugo; Morrissey, Brian; F G Cardoso, Paulo; Hays, Steven; Majid, Adnan; Pastis, Nicholas; Kopas, Lisa; Vollenweider, Mark; Michael McFadden, P; Machuzak, Michael; W Hsia, David; Sung, Arthur; Jarad, Nabil; Kornaszewska, Malgorzata; Hazelrigg, Stephen; Krishna, Ganesh; Armstrong, Brian; S Shargill, Narinder; Slebos, Dirk-Jan; Study Group, LIBERATE

doi:10.1164/rccm.201803-0590OC

Public

A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE).

Shared by NobleBlocks on Nov 1, 2018 • 12:00 AM UTC

Authors:

Gerard J Criner

Richard Sue

Shawn Wright

Abstract

RATIONALE: This is the first multicenter randomized controlled trial to evaluate the effectiveness and safety of Zephyr Endobronchial Valve (EBV) in patients with little to no collateral ventilation out to 12 months. OBJECTIVES: To evaluate the effectiveness and safety of Zephyr EBV in heterogeneous...

Subject

chronic obstructive pulmonary disease

emphysema

lung reduction

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!